BDNF and atypical Rett syndrome: This dosing regimen was based on previous work in a mouse model of Rett’s syndrome, where fingolimod (0.1 mg/kg i.p.)administration every 4 days for 2–4 weeks improved motor behavior and increased striatal and cortical BDNF levels [32].